The Vaccines and Biologics industry on FinBizNet covers 2 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 2 |
|---|---|
| Combined market cap | ₹2,246 Cr |
| Median return on equity | -9.0% |
| Companies with latest quarterly results | 2 of 2 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Panacea Biotec Ltd. | ₹2,203 Cr | — | -0.9% | ₹200 Cr | ₹2 Cr | Q1 FY27 |
| Bharat Immunologicals & Biologics Ltd | ₹43 Cr | — | -17.2% | ₹0 Cr | ₹-5 Cr | Q3 FY23 |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 2 listed companies in the Vaccines and Biologics industry: Panacea Biotec Ltd., Bharat Immunologicals & Biologics Ltd.
By market capitalisation, the largest Vaccines and Biologics companies are Panacea Biotec Ltd. (₹2,203 Cr), Bharat Immunologicals & Biologics Ltd (₹43 Cr).
The 2 Vaccines and Biologics companies tracked on FinBizNet have a combined market capitalisation of about ₹2,246 Cr.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Vaccines and Biologics industry.